Conventional MRI radiomics in patients with suspected early- or pseudo-progression

BACKGROUND: After radiochemotherapy, 30% of patients with early worsening MRI experience pseudoprogression (Psp) which is not distinguishable from early progression (EP). We aimed to assess the diagnostic value of radiomics in patients with suspected EP or Psp. METHODS: Radiomics features (RF) of 76...

Descripción completa

Detalles Bibliográficos
Autores principales: Bani-Sadr, Alexandre, Eker, Omer Faruk, Berner, Lise-Prune, Ameli, Roxana, Hermier, Marc, Barritault, Marc, Meyronet, David, Guyotat, Jacques, Jouanneau, Emmanuel, Honnorat, Jerome, Ducray, François, Berthezene, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212855/
https://www.ncbi.nlm.nih.gov/pubmed/32642655
http://dx.doi.org/10.1093/noajnl/vdz019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212855/
https://www.ncbi.nlm.nih.gov/pubmed/32642655
http://dx.doi.org/10.1093/noajnl/vdz019

Ejemplares similares